Sonnet BioTherapeutics Holdings, Inc. Gains 23.48%

Thu, Sep 22, 2022 at 07:26 PM
Sonnet BioTherapeutics Holdings, Inc. Gains 23.48%

Sonnet BioTherapeutics Holdings, Inc. (SONN:NASDAQ) rocketted at $1.63, a gain of 23.5%. On Thu, Sep 22, 2022, SONN:NASDAQ hit a New 2-Week Intraday High of $1.95. The stock got featured on our News Catalysts scanner on Wed, Sep 21, 2022 at 08:52 AM in the 'BIOTECH' category. From Thu, Sep 08, 2022, the stock recorded 50.00% Up Days and 18.18% Green Days

The stock spiked on Mon, Sep 19, 2022 at $2.29 with a volume of 1M+.

About Sonnet BioTherapeutics Holdings, Inc. (SONN:NASDAQ)

Sonnet BioTherapeutics Holdings Inc is a biotechnology company engaged in the development of biologic drugs focused on human antibody binding technology. The firm's pipeline products include SON-080 (low-dose IL-6), SON-081 (low dose IL-6), SON-1010 (IL12-FHAB), and others.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.